These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 38823469)

  • 1. Amphiphilic NLC-Gel formulation loaded with Sebacoyl dinalbuphine ester and Nalbuphine for localized postoperative pain management.
    Lin CL; Li YL; Chen YW; Kuo CH; Tu TY; Liu YF; Tsai JC; Shyong YJ
    Int J Pharm; 2024 Jun; 659():124295. PubMed ID: 38823469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Topical application of sebacoyl dinalbuphine ester-loaded nanostructured lipid carriers alleviate pruritus in scratching mouse model.
    Lin SW; Shyong YJ; Kuo PC; Tsai JC
    Int J Pharm; 2021 May; 600():120400. PubMed ID: 33636328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanostructured lipid carriers (NLC) based controlled release topical gel of clobetasol propionate: design and in vivo characterization.
    Nagaich U; Gulati N
    Drug Deliv Transl Res; 2016 Jun; 6(3):289-98. PubMed ID: 27072979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of an extended-release sebacoyl dinalbuphine ester for laparoscopic cholecystectomy: A randomized controlled trial.
    Lee YE; Fu CY; Shiue YL; Lu CY; Chen CY; Chen JH; Chen JL; Lam CF
    Medicine (Baltimore); 2023 Aug; 102(31):e34423. PubMed ID: 37543779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sebacoyl Dinalbuphine Ester Extended-release Injection for Long-acting Analgesia: A Multicenter, Randomized, Double-Blind, And Placebo-controlled Study in Hemorrhoidectomy Patients.
    Yeh CY; Jao SW; Chen JS; Fan CW; Chen HH; Hsieh PS; Wu CC; Lee CC; Kuo YH; Hsieh MC; Huang WS; Chung YC; Liou TY; Chiu HH; Tseng WK; Lee KC; Wang JY
    Clin J Pain; 2017 May; 33(5):429-434. PubMed ID: 27518486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and characterization of a novel controlled release drug delivery system based on nanostructured lipid carriers gel for meloxicam.
    Khurana S; Jain NK; Bedi PM
    Life Sci; 2013 Nov; 93(21):763-72. PubMed ID: 24113071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improvement of Pain Relief of Fentanyl Citrate Drug Encapsulated in Nanostructured Lipid Carrier: Drug Formulation, Parameter Optimization, in vitro and in vivo Studies.
    Bahrami MA; Farhadian N; Karimi M; Forouzan A; Masoumi K
    Drug Des Devel Ther; 2020; 14():2033-2045. PubMed ID: 32546968
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clotrimazole-loaded nanostructured lipid carrier hydrogels: thermal analysis and in vitro studies.
    Ravani L; Esposito E; Bories C; Moal VL; Loiseau PM; Djabourov M; Cortesi R; Bouchemal K
    Int J Pharm; 2013 Oct; 454(2):695-702. PubMed ID: 23792467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanophyto-gel against multi-drug resistant
    Wen MM; Abdelwahab IA; Aly RG; El-Zahaby SA
    Drug Deliv; 2021 Dec; 28(1):463-477. PubMed ID: 33620004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanostructured lipid carriers loaded into in situ gels for breast cancer local treatment.
    Passos JS; Apolinario AC; Ishida K; Martins TS; Lopes LB
    Eur J Pharm Sci; 2024 Jan; 192():106638. PubMed ID: 37967657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and Safety of Parenteral Injection of an Extended Release κ-receptor Opioid Sebacoyl Dinalbuphine Ester for Acute and Chronic Pain After Laparoscopic Bariatric Surgery: a Randomized, Placebo-Controlled, Double-Blind Trial.
    Lee YE; Wang SY; Chen JH; Chen CY; Shiue YL; Soong TC; Lam CF
    Obes Surg; 2023 Apr; 33(4):1192-1201. PubMed ID: 36787017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Passive and active strategies for transdermal delivery using co-encapsulating nanostructured lipid carriers: in vitro vs. in vivo studies.
    Vitorino C; Almeida A; Sousa J; Lamarche I; Gobin P; Marchand S; Couet W; Olivier JC; Pais A
    Eur J Pharm Biopharm; 2014 Feb; 86(2):133-44. PubMed ID: 24333401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and optimization of sulforaphane-loaded nanostructured lipid carriers by the Box-Behnken design for improved oral efficacy against cancer: in vitro, ex vivo and in vivo assessments.
    Soni K; Rizwanullah M; Kohli K
    Artif Cells Nanomed Biotechnol; 2018; 46(sup1):15-31. PubMed ID: 29183147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimized Nanostructured Lipid Carriers Integrated into In Situ Nasal Gel for Enhancing Brain Delivery of Flibanserin.
    Fahmy UA; Ahmed OAA; Badr-Eldin SM; Aldawsari HM; Okbazghi SZ; Awan ZA; Bakhrebah MA; Alomary MN; Abdulaal WH; Medina C; Alhakamy NA
    Int J Nanomedicine; 2020; 15():5253-5264. PubMed ID: 32801690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro and in vivo evaluation of the metabolism and pharmacokinetics of sebacoyl dinalbuphine.
    Pao LH; Hsiong CH; Hu OY; Wang JJ; Ho ST
    Drug Metab Dispos; 2005 Mar; 33(3):395-402. PubMed ID: 15608131
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tanshinol borneol ester on nanostructured lipid carriers has longer brain and systemic effector retention and better antioxidant activity in vivo.
    Yuan X; Fei F; Sun H; Xiao C; Zhao X; Zhang Y; Zheng X
    Int J Nanomedicine; 2018; 13():2265-2274. PubMed ID: 29695905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nanostructured Lipid Carrier-Based Gel for Repurposing Simvastatin in Localized Treatment of Breast Cancer: Formulation Design, Development, and In Vitro and In Vivo Characterization.
    Kumbhar PS; Manjappa AS; Shah RR; Nadaf SJ; Disouza JI
    AAPS PharmSciTech; 2023 Apr; 24(5):106. PubMed ID: 37085596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanostructured Lipid Carriers (NLC)-Based Gel Formulations as Etodolac Delivery: From Gel Preparation to Permeation Study.
    Czajkowska-Kośnik A; Szymańska E; Winnicka K
    Molecules; 2022 Dec; 28(1):. PubMed ID: 36615429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, characterization and in vivo evaluation of nanostructured lipid carriers (NLC) as a new drug delivery system for hydrochlorothiazide oral administration in pediatric therapy.
    Cirri M; Maestrini L; Maestrelli F; Mennini N; Mura P; Ghelardini C; Di Cesare Mannelli L
    Drug Deliv; 2018 Nov; 25(1):1910-1921. PubMed ID: 30451015
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chlorogenic acid stabilized nanostructured lipid carriers (NLC) of atorvastatin: formulation, design and in vivo evaluation.
    Khan S; Baboota S; Ali J; Narang RS; Narang JK
    Drug Dev Ind Pharm; 2016; 42(2):209-20. PubMed ID: 26016780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.